Los medicamentos agonistas del receptor GLP-1 (pptido similar al glucagn tipo 1) son una clase de frmacos utilizados principalmente para el tratamiento de la diabetes tipo 2 y, en algunos casos, para el manejo del peso corporal
Stretching a single pen over 812 weeks lowers monthly spend (see cost section)
Similar improvements in glycaemia and weight have been obtained with the other GLP-1 analogues and these are now firmly established in treatment pathways for diabetes, especially when priority is being given to weight loss [20]
The recommended baseline panel for menopausal women considering weight loss peptides includes: fasting glucose and HbA1c (metabolic baseline), fasting insulin (insulin resistance assessment), lipid panel including triglycerides (cardiovascular risk), complete metabolic panel (liver and kidney function), IGF-1 (baseline for GH secretagogue monitoring), thyroid panel including TSH and free T4, estradiol and FSH (menopausal status confirmation), and DEXA scan if available (body composition baseline)